JACOBS LEVY EQUITY MANAGEMENT, INC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 76 filers reported holding RECRO PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2021$1,409,000
-9.9%
684,104
+1.1%
0.01%
-18.2%
Q2 2021$1,563,000
+28.4%
676,630
+55.1%
0.01%
+22.2%
Q1 2021$1,217,000
-5.4%
436,285
-3.3%
0.01%
-18.2%
Q4 2020$1,286,000
+97.2%
451,301
+45.3%
0.01%
+57.1%
Q3 2020$652,000
-55.1%
310,630
-2.7%
0.01%
-56.2%
Q2 2020$1,452,000
+82.6%
319,159
+227.9%
0.02%
+60.0%
Q1 2020$795,000
-47.6%
97,339
+17.6%
0.01%
-33.3%
Q4 2019$1,517,000
+133.0%
82,786
+40.8%
0.02%
+87.5%
Q3 2019$651,000
+149.4%
58,786
+129.1%
0.01%
+100.0%
Q2 2019$261,000
-23.0%
25,662
-55.7%
0.00%
-20.0%
Q1 2019$339,000
+6.9%
57,864
+29.6%
0.01%
-16.7%
Q4 2018$317,000
+22.4%
44,664
+22.5%
0.01%
+50.0%
Q3 2018$259,000
+39.2%
36,464
-1.6%
0.00%
+33.3%
Q2 2018$186,000
-58.0%
37,064
-7.9%
0.00%
-57.1%
Q1 2018$443,000
+51.7%
40,264
+27.6%
0.01%
+40.0%
Q4 2017$292,000
-2.0%
31,564
-4.8%
0.01%
-16.7%
Q3 2017$298,000
+38.6%
33,164
+8.5%
0.01%
+20.0%
Q2 2017$215,00030,5640.01%
Other shareholders
RECRO PHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 2,202,420$6,145,0003.11%
Samjo Capital LLC 560,000$1,562,0001.16%
MAK CAPITAL ONE LLC 1,224,264$3,416,0000.81%
Cowen Prime Services LLC 470,500$1,313,0000.50%
Portolan Capital Management 1,957,283$5,461,0000.43%
Parkman Healthcare Partners LLC 601,967$1,679,0000.39%
Rubric Capital Management LP 1,076,587$3,004,0000.18%
Frontier Wealth Management LLC 49,112$2,142,0000.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 466,992$1,303,0000.16%
AWM Investment Company, Inc. 391,304$1,092,0000.12%
View complete list of RECRO PHARMA INC shareholders